BackOrion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War) Overview
Orion Biotech Opportunities Corp - Units (1 Ord Share Class A & 1/5 War)

Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War) P/E Ratio

Latest P/E ratio for Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War): 11.12 — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

P/E Ratio

11.12

P/E Ratio

11.12

The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.

P/E Ratio (Comparison Companies)

Loading

P/E Ratio History

Loading

P/E Ratio Comparison

Loading

Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War) (ORIAU) FAQ

The latest P/E ratio for ORIAU is 11.12. That is below the sector sector average of 34.88. Investors often review this figure alongside Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War)'s historical trend and sector peers before judging valuation or financial health.

Against its sector companies, ORIAU currently prints 11.12 for P/E ratio, while the sector average sits near 34.88. That is roughly 68.1% below the sector mean. Large gaps often invite a closer look at Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War)'s growth, margins, and balance sheet.

A P/E ratio of 11.12 for Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War) is not 'good' or 'bad' on its own. Compare it with the peer average (34.88) and with ORIAU's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting ORIAU's P/E ratio (11.12), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.